Thrombospondin-1 is highly expressed in desmoplastic components of invasive ductal carcinoma of the breast and associated with lymph node metastasis

Journal of Medical Investigation

Volumn 60, Issue 1-2, 2013, Pages 91-96

  Horiguchi, Hidehisa ^a   Yamagata, Sumiyo ^b   Qian, Zhi Rong ^a   Kagawa, Seiko ^a   Sakashita, Naomi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

Axillary lymph node; Breast carcinoma; Desmoplasia; Metastasis; Thrombospondin 1

Indexed keywords

THROMBOSPONDIN 1;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CELL; CANCER CLASSIFICATION; CANCER INVASION; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PREDICTIVE VALUE; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 84876049809     PISSN: 13431420     EISSN: 13496867     Source Type: Journal    
DOI: 10.2152/jmi.60.91     Document Type: Article

References (35)

1. Lawler JW, Slayter HS, Coligan JE: Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 253: 8609-8616, 1978
2. Iruela-Arispe ML, Lombardo M, Krutzsch HC, Lawler J, Roberts DD: Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation 100: 1423-1431, 1999
3. Locopo N, Fanelli M, Gasparini G: Clinical significance of angiogenic factors in breast cancer. Breast Cancer Res Treat 52: 159-173, 1998
4. Ren B, Yee KO, Lawler J, Khosravi-Far R: Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 1765: 178-188, 2006
5. Ebbinghaus S, Hussain M, Tannir N, Gordon M, Desai AA, Knight RA, Humerickhouse RA, Qian J, Gordon GB, Figlin R: Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinoma. Clin Cancer Res 13: 6689-6695, 2007
6. Gordon MS, Mendelson D, Carr R, Knight RA, Humerickhouse RA, Iannone M, Stopeck AT: A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer. Cancer 113: 3420-3429, 2008
7. Huang H, Campbell SC, Bedford DF, Nelius T, Veliceasa D, Shroff EH, Henkin J, Schneider A, Bouck N, Volpert OV: Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510. Mol Cancer Res 2: 541-550, 2004
8. Hyder SM, Liang Y, Wu J, Welbern V: Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells. Endocr Relat Cancer 16: 809-817, 2009
9. Firlej V, Mathieu JR, Gilbert C, Lemonnier L, Nakhlé J, Gallou-Kabani C, Guarmit B, Morin A, Prevarskaya N, Delongchamps NB, Cabon F: Thrombospondin-1 triggers cell migration and development of advanced prostate tumors. Cancer Res 71: 7649-7658, 2011
10. Roh YH, Kim YH, Choi HJ, Lee KE, Roh MS: Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer. J Hepatobiliary Pancreat Surg 16: 315-321, 2009
11. Nucera C, Porrello A, Antonello ZA, Mekel M, Nehs MA, Giordano TJ, Gerald D, Benjamin LE, Priolo C, Puxeddu E, Finn S, Jarzab B, Hodin RA, Pontecorvi A, Nose V, Lawler J, Parangi S: B-Raf(v600e) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A 107: 10649-10654, 2010
12. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF; American Society of Clinical Oncology; College of American Pathologists: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25: 118-45, 2007
13. Sobin LH, Gospodarowicz MK, Wittekind C: TNM Classification of Malignant Tumours, Seventh Edition. Blackwell Publishing Ltd., Oxford, 2010
14. Jaffe EA, Ruggiero JT, Falcone DJ: Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65: 79-84, 1985
15. Kyriakides TR, Maclauchlan S: The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J Cell Commun Signal 3: 215-225, 2009
16. Leung LL: Role of thrombospondin in platelet aggregation. J Clin Invest 74: 1764-1772, 1984
17. Mosher DF, Doyle MJ, Jaffe EA: Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol 93: 343-348, 1982
18. Murphy-Ullrich JE, Mosher DF: Localization of thrombospondin in clots formed in situ. Blood 66: 1098-1104, 1985
19. de Fraipont F, Nicholson AC, Feige JJ, Van Meir EG: Thrombospondins and tumor angiogenesis. Trends Mol Med 7: 401-407, 2001
20. John AS, Rothman VL, Tuszynski GP: Thrombospondin-1 (TSP-1) stimulates expression of integrin alpha6 in human breast carcinoma cells: A downstream modulator of TSP-1-induced cellular adhesion. J Oncol 2010: 645376, 2010
21. Lee T, Esemuede N, Sumpio BE, Gahtan V: Thrombospondin-1 induces matrix metalloproteinase-2 activation in vascular smooth muscle cells. J Vasc Surg 38: 147-154, 2003
22. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF: Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5: 1041-1056, 1999
23. Clezardin P, Frappart L, Clerget M, Pechoux C, Delmas PD: Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res 53: 1421-1430, 1993
24. Fontana A, Filleur S, Guglielmi J, Frappart L, Bruno-Bossio G, Boissier S, Cabon F, Clézardin P: Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo. Int J Cancer 116: 686-691, 2005
25. McElroy MK, Kaushal S, Tran Cao HS, Moossa AR, Talamini MA, Hoffman RM, Bouvet M: Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. Mol Cancer Ther 8: 1779-1786, 2009
26. Sid B, Langlois B, Sartelet H, Bellon G, Dedieu S, Martiny L: Thrombospondin-1 enhances human thyroid carcinoma cell invasion through urokinase activity. Int J Biochem Cell Biol 40: 1890-1900, 2008
27. Trojan L, Schaaf A, Steidler A, Haak M, Thalmann G, Knoll T, Gretz N, Alken P, Michel MS: Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res 25: 183-191, 2005
28. Iddings DM, Koda EA, Grewal SS, Parker R, Saha S, Bilchik A: Association of angiogenesis markers with lymph node metastasis in early colorectal cancer. Arch Surg 142: 738-744; discussion 744-735, 2007
29. Wang-Rodriguez J, Urquidi V, Rivard A, Goodison S: Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status. Breast Cancer Res 5: R136-143, 2003
30. Koperek O, Asari R, Niederle B, Kaserer K: Desmoplastic stromal reaction in papillary thyroid microcarcinoma. Histopathology 58: 919-924, 2011
31. Mizoi T, Ohtani H, Miyazono K, Miyazawa M, Matsuno S, Nagura H: Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: Qualitative difference between cancer cells and stromal cells. Cancer Res 53: 183-190, 1993
32. Kiyono K, Suzuki HI, Morishita Y, Komuro A, Iwata C, Yashiro M, Hirakawa K, Kano MR, Miyazono K: C-ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma. Cancer Sci 100: 1809-1816, 2009
33. Komuro A, Yashiro M, Iwata C, Morishita Y, Johansson E, Matsumoto Y, Watanabe A, Aburatani H, Miyoshi H, Kiyono K, Shirai YT, Suzuki HI, Hirakawa K, Kano MR, Miyazono K: Diffuse-type gastric carcinoma: Progression, angiogenesis, and transforming growth factor beta signaling. J Natl Cancer Inst 101: 592-604, 2009
34. Ueha S, Shand FH, Matsushima K: Cellular and molecular mechanisms of chronic inflammationassociated organ fibrosis. Front Immunol 3: 71, 2012
35. Shields MA, Dangi-Garimella S, Redig AJ, Munshi HG: Biochemical role of the collagenrich tumour microenvironment in pancreatic cancer progression. Biochem J 441: 541-552, 2012